Clinical Trial Update: Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bipolar radiofrequency ablation therapy for nonresectable bile duct cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer

Drugs mentioned

• bipolar radiofrequency ablation therapy

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Nonresectable Bile Duct Cancer | Phase 2 | Status: COMPLETED